Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-02

FDA Approved: PREGNYL — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for Pregnyl (chorionic gonadotropin alfa) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREGNYL (Chorionic gonadotropin alfa)

Snippet

SUPPL AP for PREGNYL (CHORIOGONADOTROPIN ALFA)